Man Li1, Albert Mennone1, Carol J Soroka1, Lee R Hagey2, Xinshou Ouyang1, Edward J Weinman3,4, James L Boyer1. 1. Yale Liver Center, Yale University School of Medicine, New Haven, CT. 2. Department of Medicine, University of California San Diego, La Jolla, CA. 3. Department of Medicine, University of Maryland School of Medicine, Baltimore, MD. 4. Department of Physiology, University of Maryland School of Medicine, Baltimore, MD.
Abstract
UNLABELLED: The intercellular adhesion molecule 1 (ICAM-1) is induced in mouse liver after bile duct ligation (BDL) and plays a key role in neutrophil-mediated liver injury in BDL mice. ICAM-1 has been shown to interact with cytoskeletal ezrin-radixin-moesin (ERM) proteins that also interact with the PDZ protein, Na(+) /H(+) exchanger regulatory factor 1 (NHERF-1/EBP50). In NHERF-1(-/-) mice, ERM proteins are significantly reduced in brush-border membranes from kidney and small intestine. ERM knockdown reduces ICAM-1 expression in response to tumor necrosis factor alpha. Here we show that NHERF-1 assembles ERM proteins, ICAM-1 and F-actin into a macromolecule complex that is increased in mouse liver after BDL. Compared to wild-type (WT) mice, both sham-operated and BDL NHERF-1(-/-) mice have lower levels of activated ERM and ICAM-1 protein in the liver accompanied by significantly reduced hepatic neutrophil accumulation, serum alanine aminotransferase, and attenuated liver injury after BDL. However, total bile acid concentrations in serum and liver of sham and BDL NHERF-1(-/-) mice were not significantly different from WT controls, although hepatic tetrahydroxylated bile acids and Cyp3a11 messenger RNA levels were higher in NHERF-1(-/-) BDL mice. CONCLUSION: NHERF-1 participates in the inflammatory response that is associated with BDL-induced liver injury. Deletion of NHERF-1 in mice leads to disruption of the formation of ICAM-1/ERM/NHERF-1 complex and reduction of hepatic ERM proteins and ICAM-1, molecules that are up-regulated and are essential for neutrophil-mediated liver injury in cholestasis. Further study of the role of NHERF-1 in the inflammatory response in cholestasis and other forms of liver injury should lead to discovery of new therapeutic targets in hepatic inflammatory diseases.
UNLABELLED: The intercellular adhesion molecule 1 (ICAM-1) is induced in mouse liver after bile duct ligation (BDL) and plays a key role in neutrophil-mediated liver injury in BDL mice. ICAM-1 has been shown to interact with cytoskeletal ezrin-radixin-moesin (ERM) proteins that also interact with the PDZ protein, Na(+) /H(+) exchanger regulatory factor 1 (NHERF-1/EBP50). In NHERF-1(-/-) mice, ERM proteins are significantly reduced in brush-border membranes from kidney and small intestine. ERM knockdown reduces ICAM-1 expression in response to tumor necrosis factor alpha. Here we show that NHERF-1 assembles ERM proteins, ICAM-1 and F-actin into a macromolecule complex that is increased in mouse liver after BDL. Compared to wild-type (WT) mice, both sham-operated and BDL NHERF-1(-/-) mice have lower levels of activated ERM and ICAM-1 protein in the liver accompanied by significantly reduced hepatic neutrophil accumulation, serum alanine aminotransferase, and attenuated liver injury after BDL. However, total bile acid concentrations in serum and liver of sham and BDL NHERF-1(-/-) mice were not significantly different from WT controls, although hepatic tetrahydroxylated bile acids and Cyp3a11 messenger RNA levels were higher in NHERF-1(-/-) BDL mice. CONCLUSION:NHERF-1 participates in the inflammatory response that is associated with BDL-induced liver injury. Deletion of NHERF-1 in mice leads to disruption of the formation of ICAM-1/ERM/NHERF-1 complex and reduction of hepatic ERM proteins and ICAM-1, molecules that are up-regulated and are essential for neutrophil-mediated liver injury in cholestasis. Further study of the role of NHERF-1 in the inflammatory response in cholestasis and other forms of liver injury should lead to discovery of new therapeutic targets in hepatic inflammatory diseases.
Authors: Jaspreet S Gujral; Jie Liu; Anwar Farhood; Jack A Hinson; Hartmut Jaeschke Journal: Am J Physiol Gastrointest Liver Physiol Date: 2003-10-16 Impact factor: 4.052
Authors: W A Faubion; M E Guicciardi; H Miyoshi; S F Bronk; P J Roberts; P A Svingen; S H Kaufmann; G J Gores Journal: J Clin Invest Date: 1999-01 Impact factor: 14.808
Authors: Marieke H Schoemaker; Willemijn M Gommans; Laura Conde de la Rosa; Manon Homan; Pieter Klok; Christian Trautwein; Harry van Goor; Klaas Poelstra; Hidde J Haisma; Peter L M Jansen; Han Moshage Journal: J Hepatol Date: 2003-08 Impact factor: 25.083
Authors: Marieke H Schoemaker; Laura Conde de la Rosa; Manon Buist-Homan; Titia E Vrenken; Rick Havinga; Klaas Poelstra; Hidde J Haisma; Peter L M Jansen; Han Moshage Journal: Hepatology Date: 2004-06 Impact factor: 17.425
Authors: C Gartung; M Ananthanarayanan; M A Rahman; S Schuele; S Nundy; C J Soroka; A Stolz; F J Suchy; J L Boyer Journal: Gastroenterology Date: 1996-01 Impact factor: 22.682
Authors: Adrienne Bushau-Sprinkle; Michelle Barati; Caryl Conklin; Tess Dupre; Kenneth B Gagnon; Syed J Khundmiri; Barbara Clark; Leah Siskind; Mark A Doll; Madhavi Rane; Michael Brier; Susan Coventry; Eleanor D Lederer Journal: Am J Pathol Date: 2019-03-27 Impact factor: 4.307